These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 11867132)

  • 1. Allocation concealment in randomised trials: defending against deciphering.
    Schulz KF; Grimes DA
    Lancet; 2002 Feb; 359(9306):614-8. PubMed ID: 11867132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomisation to protect against selection bias in healthcare trials.
    Odgaard-Jensen J; Vist GE; Timmer A; Kunz R; Akl EA; Schünemann H; Briel M; Nordmann AJ; Pregno S; Oxman AD
    Cochrane Database Syst Rev; 2011 Apr; 2011(4):MR000012. PubMed ID: 21491415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study.
    Pildal J; Chan AW; Hróbjartsson A; Forfang E; Altman DG; Gøtzsche PC
    BMJ; 2005 May; 330(7499):1049. PubMed ID: 15817527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the influence of randomisation sequence generation and allocation concealment on treatment effects of physical therapy trials? A meta-epidemiological study.
    Armijo-Olivo S; Saltaji H; da Costa BR; Fuentes J; Ha C; Cummings GG
    BMJ Open; 2015 Sep; 5(9):e008562. PubMed ID: 26338841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using scratch card technology for random allocation concealment in a clinical trial with a crossover design.
    Beksinska ME; Joanis C; Smit JA; Pienaar J; Piaggio G
    Clin Trials; 2013 Feb; 10(1):125-30. PubMed ID: 23188890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subverting randomization in controlled trials.
    Schulz KF
    JAMA; 1995 Nov; 274(18):1456-8. PubMed ID: 7474192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allocation concealment: a methodological review.
    Clark L; Schmidt U; Tharmanathan P; Adamson J; Hewitt C; Torgerson D
    J Eval Clin Pract; 2013 Aug; 19(4):708-12. PubMed ID: 23648092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Selection Bias on Treatment Effect Size Estimates in Randomized Trials of Oral Health Interventions: A Meta-epidemiological Study.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    J Dent Res; 2018 Jan; 97(1):5-13. PubMed ID: 28813182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomization and allocation concealment: a practical guide for researchers.
    Doig GS; Simpson F
    J Crit Care; 2005 Jun; 20(2):187-91; discussion 191-3. PubMed ID: 16139163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and direction of allocation bias in randomised clinical trials.
    Paludan-Müller A; Teindl Laursen DR; Hróbjartsson A
    BMC Med Res Methodol; 2016 Oct; 16(1):133. PubMed ID: 27717321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of allocation sequences in randomised trials: chance, not choice.
    Schulz KF; Grimes DA
    Lancet; 2002 Feb; 359(9305):515-9. PubMed ID: 11853818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials.
    Kunz R; Oxman AD
    BMJ; 1998 Oct; 317(7167):1185-90. PubMed ID: 9794851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool.
    Corbett MS; Higgins JP; Woolacott NF
    Res Synth Methods; 2014 Mar; 5(1):79-85. PubMed ID: 26054027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
    Pildal J; Hróbjartsson A; Jørgensen KJ; Hilden J; Altman DG; Gøtzsche PC
    Int J Epidemiol; 2007 Aug; 36(4):847-57. PubMed ID: 17517809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomization in clinical trials in orthodontics: its significance in research design and methods to achieve it.
    Pandis N; Polychronopoulou A; Eliades T
    Eur J Orthod; 2011 Dec; 33(6):684-90. PubMed ID: 21320892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the validity of clinical trials.
    Akobeng AK
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor reporting quality of key Randomization and Allocation Concealment details is still prevalent among published RCTs in 2011: a review.
    Clark L; Schmidt U; Tharmanathan P; Adamson J; Hewitt C; Torgerson D
    J Eval Clin Pract; 2013 Aug; 19(4):703-7. PubMed ID: 23648066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different methods of allocation to groups in randomized trials are associated with different levels of bias. A meta-epidemiological study.
    Herbison P; Hay-Smith J; Gillespie WJ
    J Clin Epidemiol; 2011 Oct; 64(10):1070-5. PubMed ID: 21474279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subversion of allocation concealment in a randomised controlled trial: a historical case study.
    Kennedy ADM; Torgerson DJ; Campbell MK; Grant AM
    Trials; 2017 May; 18(1):204. PubMed ID: 28464922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.